Adicet Bio, Inc. (ACET) stock forecast and price target
Price $2.78 · data as of November 13, 2026
12-month price target
Average target$29.00
Upside / downside+943.2%
Analysts6
ConsensusStrong buy
Low $18.00Average $29.00High $55.00
Gold marker: average target · white marker: today’s price ($2.78)
Analyst ratings
Strong buy 0Buy 6Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-7.33 | +56.8% | $0 |
| Next fiscal year ends December 31, 2027 | $-4.82 | +34.2% | $0 |
| Next quarter ends December 31, 2026 | $-1.80 | +38.6% | $0 |
| Quarter after ends March 31, 2027 | $-1.49 | +20.6% | $0 |
Consensus of the analysts covering Adicet Bio, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.
Frequently asked questions
What is the Adicet Bio stock price target?
The average 12-month target from 6 analysts is $29.00, 943.2% above the current price of $2.78 Targets range from $18.00 to $55.00.
Is Adicet Bio a buy according to analysts?
The consensus rating is “Strong buy” (6 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Adicet Bio expected to earn?
Analysts expect EPS of $-7.33 for the fiscal year ending December 31, 2026 and $-4.82 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.